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Introduction. We sought to compare the performance of endovascular cooling to conventional surface cooling after cardiac arrest.
Methods. Patients in coma following cardiopulmonary resuscitation were cooled with an endovascular cooling catheter or with
ice bags and cold-water-circulating cooling blankets to a target temperature of 32.0–34.0◦C for 24 hours. Performance of cooling
techniques was compared by (1) number of hourly recordings in target temperature range, (2) time elapsed from the written order
to initiate cooling and target temperature, and (3) adverse events during the ﬁrst week. Results. Median time in target temperature
range was 19 hours (interquartile range (IQR), 16–20) in the endovascular group versus. 10 hours (IQR, 7–15) in the surface group
(P = .001). Median time to target temperature was 4 (IQR, 2.8–6.2) and 4.5 (IQR, 3–6.5) hours, respectively (P = .67). Adverse
events were similar. Conclusion. Endovascular cooling maintains target temperatures better than conventional surface cooling.
1.Introduction
Each year an estimated 165,000 people in the United States
have an out-of-hospital cardiac arrest, and many more
undergo in-hospital resuscitation [1–4]. Those that survive
may have devastating neurological impairments from glob-
al ischemic brain injury. Mild-to-moderate therapeutic hy-
pothermia for 12 to 24 hours has been shown to improve
neurological outcome in two randomized clinical trials of
comatose survivors following out-of-hospital ventricular f-
ibrillation arrest [5, 6]. Based on the results of these
trials, the 2005 American Heart Association guidelines for
Cardiopulmonary Resuscitation and Emergency Cardiovas-
cular Care recommended to consider the use of therapeutic
hypothermia for unconscious adult patients with return
of spontaneous circulation after witnessed out-of-hospital
ventricular ﬁbrillation arrest (Class IIA) and nonventricular
ﬁbrillation and in-hospital cardiac arrest (Class IIB) [7].
The 2010 guidelines continue to recommend therapeutic
hypothermia in these patients, now as Class I and Class IIB
recommendations, respectively [8].
In spite of the data and guidelines hospitals in the United
States have been slow to adopt therapeutic hypothermia
in the routine management of comatose postcardiac arrest
patients [9]. This may be in part explained by physician
unfamiliarity with therapeutic hypothermia and in part by
the labor intensiveness and inaccuracy of surface cooling
using ice bags and cooling blankets [10]. Most studies to date
have used conventional surface-based cooling techniques
(ice bags and cool air or water blankets), which are generally2 Stroke Research and Treatment
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Figure 1: Hourly bladder temperature recordings of each patient
from the time point that the cooling protocol was initiated to the
end of active cooling (24 hours). (a) Endovascular-cooled group
(n = 26). (b) Surface-cooled group (n = 15).
slow and imprecise in achieving and maintaining target
temperature. Animal models suggest that a delay in cooling
abates the neurological beneﬁts of mild hypothermia and
that deep hypothermia has no added beneﬁt over mild-
to-moderate hypothermia [11, 12]. Endovascular cooling
techniques have shown promise in providing more rapid and
precise temperature regulation than conventional surface
cooling techniques and have been shown to be feasible
in postcardiac arrest patients, but data on their utility is
scarce [13–16]. The purpose of this study is to compare the
performance of endovascular versus conventional surface-
based cooling in comatose postcardiac arrest patients.
2.MaterialsandMethods
This was a longitudinal comparative study of consecutive
comatose postcardiac arrest survivors, who were treated with
our institution’s hypothermia protocol (see the appendix).
All patients were sedated and paralyzed to ensure comfort
and prevent shivering. Target core temperature measured by
bladder temperature was 32.0–34.0◦C for 24 hours followed
by spontaneous or passive rewarming over 12 hours. The
start of the 24-hour cooling period was designated as
the time of the written order to initiate the therapeutic
hypothermia protocol and included the organizational time
required for setting up the surface or endovascular cooling
equipment and for the catheter insertion. All patients had
bladder temperatures recorded hourly from the initiation
of the cooling protocol. This study was approved by our
institutional review board.
The study spanned the time period between February
2004 and September 2006 (∼2.5 years). Between February
2004 and February 2005, hypothermia was induced using
cold-water-circulating cooling blankets (Mul-T-Blanket with
Gaymar Medi Therm III, Gaymar Industries, Orchard Park,
NY)andicebags.InFebruary2005ourinstitution converted
to endovascular cooling using the Celsius Control System
(Innercool Therapies, San Diego, CA) catheter. This catheter
system has a feedback loop controlling target temperature by
using a temperature sensing esophageal probe. In patients
who underwent endovascular cooling, surface cooling was
initiated until the catheter could be inserted. Patients did
not receive ice-cooled intravenous ﬂuids. The catheter was
removed at the end of the 24-hour cooling period, and
spontaneous or passive rewarming occurred over 12 hours.
The performance of endovascular versus surface-based
cooling was compared by assessing the following variables:
(1) number of hourly recordings in target temperature
range (32–34◦C) during the 24-hour cooling period, (2)
time elapsed from the written orders to initiate the cooling
protocol and the target temperature achieved (time required
to insert the catheter was included in this time period), and
(3) frequency of predeﬁned adverse events possibly related
to hypothermia or the use of an endovascular catheter or
surface cooling technique during the ﬁrst 7 days after cardiac
arrest.Datawascollectedusingthepatients’medicalrecords.
Details of the diagnostic criteria for adverse events may be
found at the bottom of Table 1.
2.1. Statistical Analysis. Continuous variables were analyzed
with the Wilcoxon Rank-Sum test. Categorical variables were
analyzed with the Fisher’s exact test. Group diﬀerences were
considered signiﬁcant at P<. 05.
3. Results
Forty-one cardiac arrest patients underwent hypothermia
between February 2004 and September 2006 at our hospital:
15 with surface and 26 with endovascular cooling. In
ﬁve patients in whom hypothermia was considered using
endovascular cooling, surface cooling was used instead,
because of a failed attempt at catheter placement (N = 1),
a contraindication to catheter placement (N = 2) or the
general ICU team preferred surface cooling (N = 2). There
were no diﬀerences in baseline characteristics between the
two groups except for a higher proportion of patients with
ventricular ﬁbrillation arrest in the endovascular group and
a strong trend towards a higher proportion of renal failure
on admission in the surface cooling group (Table 1). Figure 1
shows the temperature curves of each patient in both groups.
The median duration within target temperature range was
19 of the 24 hours (interquartile range (IQR), 16–20) for
the endovascular group versus 10 hours (IQR, 7–15) for
the surface cooling group (P = .0001). Median time from
initiation of the cooling protocol to target temperature
was 4 hours (240 minutes) (IQR, 2.8–6.2 hours) in the
endovascular group versus 4.5 hours (270 minutes) (IQR,
3–6.5 hours) in the surface group (P = NS). All patients
in the endovascular group reached target temperature, butStroke Research and Treatment 3
Table 1: Baseline characteristics and adverse events duringthe ﬁrstweek in the endovascular-(N = 26) and surface-cooled groups (N = 15).
Characteristic/adverse event Endovascular number (%) Surface number (%) P valuea
Baseline characteristic
Mean age (years) 63 ±17 58 ±15 .28
Sex (males) 18 (69%) 12 (80%) .22
Mean weight (kg) 82 ±21 95 ±37 .15
Duration of the arrest (min) 31 24 .13
Ventricular ﬁbrillation arrests 12 (46%) 1 (7%) .008
Median time from arrest to initiation of cooling protocol (min) 277 481 .16
Median Bladder T at initiation of cooling (◦C) 36.4 36.4 .76
Renal failure on admissionb 10 (38%) 10 (67%) .06
Adverse Events
Hypotensionc 10 (38%) 4 (27%) .21
Bradycardiad 18 (69%) 8 (53%) .16
Other arrhythmias 6 (23%) 4 (27%) .28
New infection in 1st week 16 (62%) 8 (53%) .23
Pneumonia 14 (54%) 7 (47%) .23
Sepsis 1 (4%) 0 (0%) .63
Pancreatitis 0 (0%) 0 (0%) —
Renal failure 1st weeke 6 (23%) 4 (27%) .25
Hemodialysis 1 (4%) 1 (7%)f .48
Coagulopathyg 6 (23%) 4 (27%) .77
Groin hematoma 0 (0%) N/A —
Skin injury 0 (0%) 0 (0%) —
Transfusion pRBC 6 (23%) 4 (27%) .28
Transfusion of platelets 1 (4%) 0 (0%) .63
Seizuresh 2 (8%) 2 (13%) .33
Deep venous thrombosisi 3 (12%) 1 (7%) .38
Pulmonary embolism 1 (4%) 0 (0%) .63
aP values calculated from Fisher’s exact test and Wilcoxon rank-sum test; bcreatinine ≥1.5mg/dL; cmean arterial pressure <70mm Hg and requiring pressors;
dheart rate <60/min; erise in creatinine ≥0.5mg/dL; falready on hemodialysis as outpatient; gINR >1.5 or PTT > 40sec within 48 hours of cooling; hnot
including clinical evidence of status myoclonus.
one patient in the surface group never did. Three patients
(12%) in the endovascular group had temperatures below
32◦C for more than one hour, compared to 7 (47%) in the
surface group (P = .022). However, one of the endovascular
patients was initially treated with surface cooling and started
oﬀ below target temperature. Median time from actual
physical insertion of the catheter to target temperature was
114 minutes (IQR, 30–199). The frequency of predeﬁned
adverse events related to cooling or cooling technology in the
ﬁrst week was similar in both groups (Table 1). There was a
trend towards more frequent hypotension and arrhythmias
in the endovascular group. No catheter-related procedural
complications and no skin injuries were observed. Mortality
was 62% (16/26) for the endovascular group and 73%
(11/15) for the surface group. Twenty-six percent of the
patients in the endovascular group were discharged home,
4% to a rehabilitation facility, and 8% to a nursing home.
Of the surface group, 7% went home, 7% went to a
rehabilitation facility, and 13% went to a nursing home.
4. Discussion
The results of this study demonstrate that temperature con-
trol using the Celsius Control System Innercool catheter is
more accurate in keeping patients in the target temperature
range than surface cooling with ice bags and cooling
blankets. Two similar studies also found that endovascular
cooling is superior to surface cooling in maintaining a
target temperature [15, 16]. Further, another study found
that unintentional overcooling occurred in the majority
of patients (63%) treated with ice bags and conventional
cooling blankets [17]. In our study this occurred in 12%
of the patients in the endovascular group and 47% of the
surface group. Accurate temperature control is important4 Stroke Research and Treatment
as body temperatures above target temperature may oﬀer
less neuroprotection and body temperatures below target
may produce more pronounced side eﬀects. The observed
trend of higher frequencies of hypotension and bradycardia
in our endovascular group probably may reﬂect an overall
longer duration of lower body temperatures in this group
during the cooling maintenance phase compared to the
surface group but it may also be related to the position of
the catheter in relative proximity to the heart.
We felt that a pragmatic comparison between the two
cooling methods in our study was the most appropriate
and decided to compare them from the time point that
it was decided to initiate the cooling protocol to reaching
target temperature, hence including the organizational time
required to implement each one of the two cooling tech-
niques. After all, if one technique cools patients faster than
another, but requires more time to initiate because of process
issues, its apparent beneﬁt may be negated. We observed a
trendtoreachtargettemperaturesfasterintheendovascular-
cooled group despite the additional time required to move
the patient to an intensive care unit bed or the cardiac
catheterization laboratory prior to insertion of the catheter.
Furthermore, sometimes a neurointensivist traveled from
hometoplacethecatheter.Adjunctcoolingmethods,suchas
ice-cooled intravenous ﬂuid infusions, might have decreased
the time to target temperature in both groups but were not
used during the study period [18].
There was a trend towards better neurologic outcomes
in the endovascular group. This ﬁnding may be based on
imbalances in baseline characteristics and should not be
interpreted as a suggestion of better clinical outcomes with
endovascular cooling. Further, with increasing familiarity
with the use of hypothermia at our institution, the time from
arrest to initiation of cooling protocol decreased over time
and tended to be less in the endovascular group. Thus, data
of this study cannot be used to compare the clinical beneﬁt
of endovascular with surface cooling.
While this study did not speciﬁcally measure nursing
satisfaction with the two cooling techniques, part of the
reason we changed to endovascular cooling from surface
cooling was that the nursing staﬀ found the surface method
very labor intensive. The application and removal of the ice
bags and cooling blankets to maintain the target temperature
was diﬃcult and time consuming for the nursing staﬀ.
Despite the nurses eﬀorts some patients would remain above
or below the target range. The endovascular method, once
in place, frees the nurse to focus on other duties, because
temperature is automatically maintained in target range.
Both techniques require an additional piece of equipment
to be in the patient’s room and make transporting a patient
more cumbersome. Special attention must be paid by the
nurse when turning or transporting the endovascularly
cooledpatientasthepatient’slegmustbekeptstraightonthe
insertion side. For the physician the endovascular technique
is more labor intensive, and for those unfamiliar with the
device it will require procedural training for placement.
Limitations of this study include its nonrandomized de-
sign and imbalances in the baseline characteristics between
the two groups; however, we intended to compare perfor-
mance of cooling technologies and not patient outcome. It
is possible that newer, more sophisticated surface cooling
technology, such as adhesive surface devices with patient
temperature feedback to computer-controlled temperature
management systems, performs even better than endovas-
cular cooling techniques. Similarly, there may also be
diﬀerences in performance among various commercially
available cooling catheters. Other studies have reported
eﬀective temperature control and safety with the Icy catheter
and CoolGard system [13, 14]. Finally we did not do a cost
comparison between the two groups.
5. Conclusions
Endovascular cooling to mild-to-moderate hypothermia is
feasible in comatose postcardiac arrest patients. When com-
pared with conventional surface cooling it is more accurate
in maintaining target temperature, but it is not faster in
terms of reaching target temperature, because of time lost to
logistic issued associated with catheter insertion and setting
up the cooling console. Further studies are needed to assess
if diﬀerences in cooling accuracy translate into better clinical
outcomes.
Disclosure
The authors have reported no conﬂicts of interest. The use
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Appendix
A. Stanford Therapeutic Hypothermia after
CardiacArrestProtocol
This is adapted from the University of California San Fran-
cisco hypothermia after cardiac arrest cooling protocol with
permission.
A.1. Inclusion Criteria
(1) Age 18 years or older.
(2) Womenmustbeover50orhaveanegativepregnancy
test.
(3) Cardiac arrest with return of normal sinus rhythm.
(4) Persistent coma as evidenced by no eye opening to
pain after resuscitation (no waiting period required).
(5) Blood pressure can be maintained at least at 90mm
Hg systolic either spontaneously or with ﬂuid and
pressor (no aortic balloon pump unless approved by
cardiology).
(6) Modiﬁed Rankin scale 0–2 prior to the arrest.Stroke Research and Treatment 5
A.2. Exclusion Criteria
(1) Any other overt reason to be comatose (e.g., sedating
drugs, drug overdose, status epilepticus).
(2) Pregnancy.
(3) A known terminal illness preceding the arrest.
(4) Known pre-existing coagulopathy or bleeding.
(5) Pre-existing do not intubate code status and patient
not intubated as part of the resuscitation eﬀorts.
A.3. Protocol(GoalTemperature33.0◦CtoBeA chievedasSoon
as Possible)
(1) Hypothermia should be initiated as quickly as pos-
sible. For out-of-hospital arrests the ED attending in
conjunction with the neurocritical care/stroke team
willmakethedecisiontoimplementtheprotocol.For
in-hospital arrests, the neurocritical care/stroke team
in conjunction with the CCU or ICU fellow in charge
of the patient will make the decision.
(2) Page Neurology resident in house for immedi-
ate neurological assessment prior to pharmacologic
paralysis. Do not delay initiation of cooling pending
assessment.
(3) Immediately place ice bags under the armpits, next to
the neck, on the torso and limbs.
(4) Temperature sensing Foley catheter should be placed,
otherwise rectal or tympanic temperatures should be
used (in that order) until Foley placement.
(5) Two cooling blankets should be used, one under and
one over the patient. Both should be set to maximum
cooling.
(6) The room thermostat should be turned oﬀ.
(7) Administer midazolam and fentanyl for sedation or
other sedatives as ordered by the primary team.
(8) Once sedation is started and eﬀective, give a vecuro-
nium bolus, then continuous drip for paralysis or
other paralyzing agent as ordered by the primary
team. Titrate the drip to keep 1–2/4 twitches on train
of four.
(9) Patientsshouldbeonslidingscaleinsulintomaintain
glucose between 151–200mg/dL, daily aspirin, pres-
sorstomaintainbloodpressure,andanyantiarrhyth-
mics as necessary. Place nasogastric tube for meds.
(10) Patients may receive other cardiac interventions
including systemic thrombolysis, anticoagulation,
and urgent cardiac catheterization interventions as
needed. Hypothermia should proceed concurrent
with these interventions.
(11) Once the patient reaches 34◦C, remove the ice packs
and top cooling blanket if necessary. The goal is
for the patient’s temperature to remain between 32–
34◦C.
(12) Beginpassiverewarming24hoursafterthebeginning
of cooling (not 24 hours after target temperature
is reached). The goal is to reach 36.5–37◦C( I f
temperature increases over 37.5◦C restart cooling
blankets).
(a) Turn room thermostat up to normal.
(b) Discontinue cooling blankets.
(c) May use regular blankets.
(d) Do not use warm air blankets unless temper-
ature not at 36◦C after 12 hours of passive
rewarming.
(13) Paralysis, then sedation, may be discontinued after
rewarming to 36.5◦C.
A.4. Supplement—Use of Endovascular Cooling Catheter.
(1) The neurocritical care/stroke team should be paged
as part of the standard protocol for considering
hypothermia following cardiac arrest. The neurocrit-
ical care/stroke team will evaluate the patient for
endovascular cooling.
(2) External cooling should be initiated immediately as
per the standard protocol, pending evaluation for
endovascular cooling. Patient must be able to tolerate
large-bore catheter (as large as 14 F) into the inferior
vena cava via a femoral vein.
(3) If possible inform family members of the procedure
and its risks and beneﬁts and make a note of this in
the chart.
(4) Equipment needed for endovascular cooling:
(a) innercool console,
(b) console-related equipment,
(c) cooling catheter equipment.
(5) The neurocritical care/stroke team will place the
endovascular catheter. Cooling will then be initiated
usingtheinnercoolconsoletoatargettemperatureof
33◦C for 24 hours. All external cooling elements may
be discontinued. Rewarming will take place passively
over 12 hours to a target temperature of 36.5–37◦C.
(6) An abdominal X-ray should be obtained following
placement of the catheter, but initiation of the
endovascular cooling should not be delayed pending
the result of the study.
(7) Sedation, paralytics and mechanical ventilation
shouldbeemployedaspartofthestandardhypother-
mia after cardiac arrest protocol.
(8) Patients may receive other cardiac interventions,
including systemic thrombolysis, anticoagulation
and urgent cardiac intervention as needed.
(9) The neurocritical care team will remove the catheter
at the end of the 24-hour cooling period.
(10) Start heparin subcutaneously 5000 unit q 12 hours,
12 hours after the catheter is removed.6 Stroke Research and Treatment
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